Novo Nordisk’s obesity drug Wegovy cleared to treat live disease MASH
Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators on Friday to treat an increasingly common liver disease, adding ...
Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators on Friday to treat an increasingly common liver disease, adding ...
A good Thursday to you all, with Andrew Joseph here in London filling in for Mr. Pharmalot. A busy August ...
Credit: CC0 Public Domain In the first multinational study of a proposed change to how obesity is defined—which calls for ...
CHICAGO — Late-stage results of Novo Nordisk’s obesity candidate CagriSema suggest the drug is comparable to Eli Lilly’s Zepbound on ...
A new long-term study published in BMJ Medicine suggests that children born to very obese mothers (those with a body ...
New research being presented at this year's European Congress on Obesity (ECO 2025) has found that patients of an online ...
Researchers at the Tohoku University Graduate School of Medicine have uncovered a key primary step in the hepatic ERK pathway ...
New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that ...
The pleasure we get from eating junk food - the dopamine rush from crunching down on salty, greasy French fries ...
Credit: CC0 Public Domain New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.